Your browser doesn't support javascript.
loading
Application of Lepidic Component Predominance to Adjuvant Chemotherapy with Oral Fluoropyrimidines for Stage I Lung Adenocarcinoma.
Sasada, Shinsuke; Miyata, Yoshihiro; Mimae, Takahiro; Tsutani, Yasuhiro; Mimura, Takeshi; Okada, Morihito.
Afiliação
  • Sasada S; Department of Surgical Oncology, Hiroshima University, Hiroshima, Japan.
  • Miyata Y; Department of Surgical Oncology, Hiroshima University, Hiroshima, Japan.
  • Mimae T; Department of Surgical Oncology, Hiroshima University, Hiroshima, Japan.
  • Tsutani Y; Department of Surgical Oncology, Hiroshima University, Hiroshima, Japan.
  • Mimura T; Department of Surgical Oncology, Hiroshima University, Hiroshima, Japan.
  • Okada M; Department of Surgical Oncology, Hiroshima University, Hiroshima, Japan. Electronic address: morihito@hiroshima-u.ac.jp.
Clin Lung Cancer ; 17(5): 433-440.e1, 2016 09.
Article em En | MEDLINE | ID: mdl-26725850

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pirimidinas / Adenocarcinoma / Neoplasias Pulmonares / Antineoplásicos Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pirimidinas / Adenocarcinoma / Neoplasias Pulmonares / Antineoplásicos Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article